These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22025325)

  • 1. RECK overexpression decreases invasive potential in prostate cancer cells.
    Rabien A; Ergün B; Erbersdobler A; Jung K; Stephan C
    Prostate; 2012 Jun; 72(9):948-54. PubMed ID: 22025325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression and significance of the matrix metalloproteinase inhibitor RECK gene in prostate cell strains].
    Xu ZY; Gao JP; Zhang ZP; Ge JP; Xu CL; Sun YH
    Zhonghua Nan Ke Xue; 2005 Oct; 11(10):727-30. PubMed ID: 16281502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RECK overexpression reduces invasive ability in ameloblastoma cells.
    Liang QX; Liang YC; Xu ZY; Chen WL; Xie HL; Zhang B
    J Oral Pathol Med; 2014 Sep; 43(8):613-8. PubMed ID: 24646032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of urokinase plasminogen activator and matrix metalloproteinases and up-regulation of their inhibitors by a novel nutrient mixture in human prostate cancer cell lines PC-3 and DU-145.
    Roomi MW; Kalinovsky T; Rath M; Niedzwiecki A
    Oncol Rep; 2011 Dec; 26(6):1407-13. PubMed ID: 21874261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of the RECK-tumor and metastasis suppressor gene in glioma invasiveness.
    Correa TC; Brohem CA; Winnischofer SM; da Silva Cardeal LB; Sasahara RM; Taboga SR; Sogayar MC; Maria-Engler SS
    J Cell Biochem; 2006 Sep; 99(1):156-67. PubMed ID: 16791855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer.
    Takeuchi T; Hisanaga M; Nagao M; Ikeda N; Fujii H; Koyama F; Mukogawa T; Matsumoto H; Kondo S; Takahashi C; Noda M; Nakajima Y
    Clin Cancer Res; 2004 Aug; 10(16):5572-9. PubMed ID: 15328199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RECK expression in pancreatic cancer: its correlation with lower invasiveness and better prognosis.
    Masui T; Doi R; Koshiba T; Fujimoto K; Tsuji S; Nakajima S; Koizumi M; Toyoda E; Tulachan S; Ito D; Kami K; Mori T; Wada M; Noda M; Imamura M
    Clin Cancer Res; 2003 May; 9(5):1779-84. PubMed ID: 12738734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of CD44v3-v10 on adhesion, invasion and MMP-14 expression in prostate cancer cells.
    Harrison GM; Davies G; Martin TA; Mason MD; Jiang WG
    Oncol Rep; 2006 Jan; 15(1):199-206. PubMed ID: 16328056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mRNA expression of the five membrane-type matrix metalloproteinases MT1-MT5 in human prostatic cell lines and their down-regulation in human malignant prostatic tissue.
    Jung M; Römer A; Keyszer G; Lein M; Kristiansen G; Schnorr D; Loening SA; Jung K
    Prostate; 2003 May; 55(2):89-98. PubMed ID: 12661033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RECK expression in osteosarcoma: correlation with matrix metalloproteinases activation and tumor invasiveness.
    Kang HG; Kim HS; Kim KJ; Oh JH; Lee MR; Seol SM; Han I
    J Orthop Res; 2007 May; 25(5):696-702. PubMed ID: 17262820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression of angiogenic factors correlates with metastatic potential of prostate cancer cells.
    Aalinkeel R; Nair MP; Sufrin G; Mahajan SD; Chadha KC; Chawda RP; Schwartz SA
    Cancer Res; 2004 Aug; 64(15):5311-21. PubMed ID: 15289337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bax inhibitor-1 is overexpressed in prostate cancer and its specific down-regulation by RNA interference leads to cell death in human prostate carcinoma cells.
    Grzmil M; Thelen P; Hemmerlein B; Schweyer S; Voigt S; Mury D; Burfeind P
    Am J Pathol; 2003 Aug; 163(2):543-52. PubMed ID: 12875974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of MT1-MMP and RECK protein in human gastric carcinoma].
    Shen B; Zheng MQ; Xu XY; Mo FG; Zhang T; Feng JF
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Oct; 25(5):364-7. PubMed ID: 22338226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and functional role of CCR9 in prostate cancer cell migration and invasion.
    Singh S; Singh UP; Stiles JK; Grizzle WE; Lillard JW
    Clin Cancer Res; 2004 Dec; 10(24):8743-50. PubMed ID: 15623660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of Fn14 promotes androgen-independent prostate cancer progression through MMP-9 and correlates with poor treatment outcome.
    Huang M; Narita S; Tsuchiya N; Ma Z; Numakura K; Obara T; Tsuruta H; Saito M; Inoue T; Horikawa Y; Satoh S; Habuchi T
    Carcinogenesis; 2011 Nov; 32(11):1589-96. PubMed ID: 21828059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasoactive intestinal peptide behaves as a pro-metastatic factor in human prostate cancer cells.
    Fernández-Martínez AB; Bajo AM; Sánchez-Chapado M; Prieto JC; Carmena MJ
    Prostate; 2009 May; 69(7):774-86. PubMed ID: 19189304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RECK-mediated inhibition of glioma migration and invasion.
    Silveira Corrêa TC; Massaro RR; Brohem CA; Taboga SR; Lamers ML; Santos MF; Maria-Engler SS
    J Cell Biochem; 2010 May; 110(1):52-61. PubMed ID: 20127710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RRR-alpha-tocopheryl succinate inhibits human prostate cancer cell invasiveness.
    Zhang M; Altuwaijri S; Yeh S
    Oncogene; 2004 Apr; 23(17):3080-8. PubMed ID: 15048090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased RECK and Increased EMMPRIN expression in urothelial carcinoma of the bladder are associated with tumor aggressiveness.
    Wittschieber D; Stenzinger A; Klauschen F; Stephan C; Jung K; Erbersdobler A; Rabien A
    Pathobiology; 2011; 78(3):123-31. PubMed ID: 21613799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-tumor effect of ascorbic acid, lysine, proline, arginine, and epigallocatechin gallate on prostate cancer cell lines PC-3, LNCaP, and DU145.
    Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
    Res Commun Mol Pathol Pharmacol; 2004; 115-116():251-64. PubMed ID: 17564322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.